Guided Therapeutics, Inc. Stock
Stocks
GTHP
US40171F5017
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
00:12:26 30/05/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.2290 USD | -.--% |
|
+34.71% | -57.59% |
| Market Cap | 13.97M 12.51M 11.51M 10.43M 19.49M 1.33B 19.85M 137M 55.08M 698M 52.42M 51.31M 2.2B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 16.84M 15.09M 13.88M 12.57M 23.5M 1.6B 23.94M 165M 66.43M 841M 63.21M 61.87M 2.65B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +34.71% | ||
| Current month | -7.62% | ||
| 1 month | +14.50% | ||
| 3 months | -23.67% | ||
| 6 months | +14.50% | ||
| Current year | -57.59% |
| 1 week | 0.13 | 0.23 | |
| 1 month | 0.13 | 0.24 | |
| Current year | 0.13 | 0.54 | |
| 1 year | 0.13 | 0.54 | |
| 3 years | 0.06 | 0.54 | |
| 5 years | 0.06 | 0.78 | |
| 10 years | 0.02 | 3,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/3/26 | Free | Chairman | 110,000 | 0.1316% | ||
| 10/3/26 | Others | Director | 466,991 | 0.5586% | ||
| 10/3/26 | Free | Director | 110,000 | 0.1316% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +34.71% | -0.43% | +37.13% | 13.97M | ||
| -1.72% | +3.44% | +25.31% | +60.56% | 262B | ||
| -2.00% | +0.75% | +7.99% | +25.46% | 167B | ||
| -3.73% | -4.48% | -18.49% | +67.13% | 156B | ||
| -1.66% | -8.12% | -58.26% | -16.12% | 61.87B | ||
| -2.57% | +3.30% | +10.22% | +47.55% | 54.44B | ||
| 0.00% | +2.71% | -13.09% | -6.48% | 53.3B | ||
| -3.47% | +1.04% | +21.98% | +72.85% | 51.07B | ||
| +0.84% | -3.12% | +9.80% | +64.47% | 50.25B | ||
| -3.61% | +1.99% | +34.94% | +95.49% | 47.17B | ||
| Average | -1.59% | +1.52% | +2.00% | +44.80% | 90.26B | |
| Weighted average by Cap. | -1.63% | +2.44% | +5.11% | +47.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.27K 5.77K 5.23K 9.77K 665K 9.95K 68.77K 27.61K 350K 26.27K 25.71K 1.1M | 767K 687K 632K 573K 1.07M 72.83M 1.09M 7.54M 3.02M 38.31M 2.88M 2.82M 121M |
| Net income | -2.42M -2.16M -1.99M -1.8M -3.37M -229M -3.44M -23.74M -9.53M -121M -9.07M -8.88M -381M | -3.2M -2.86M -2.63M -2.39M -4.46M -303M -4.54M -31.4M -12.6M -160M -11.99M -11.74M -503M |
| Net Debt | 1.77M 1.59M 1.46M 1.32M 2.47M 168M 2.52M 17.4M 6.98M 88.46M 6.65M 6.51M 279M | 2.88M 2.58M 2.37M 2.15M 4.01M 273M 4.09M 28.25M 11.34M 144M 10.79M 10.56M 453M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | US$0.1447 | -1.69% | 1,000 |
| 28/10/26 | US$0.1472 | +1.48% | 1,951 |
| 27/10/26 | US$0.1450 | +9.95% | 1,127 |
| 26/10/26 | US$0.1319 | -9.03% | 1,003 |
| 23/10/26 | US$0.1450 | -14.71% | 10,272 |
- Stock Market
- Stocks
- GTHP Stock
Select your edition
All financial news and data tailored to specific country editions
















